Bio Essence Corporation
BIOE
$0.0937
$0.00272.97%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.90K | -205.80K | -27.60K | -1.20M | -215.70K |
| Total Depreciation and Amortization | 100.00 | 100.00 | 300.00 | 100.00 | 300.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.60K | 13.80K | 15.60K | 1.23M | 125.60K |
| Change in Net Operating Assets | 96.30K | 165.90K | 434.70K | 325.70K | 105.00K |
| Cash from Operations | 167.80K | -26.10K | 423.10K | 357.10K | 15.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -100.00 | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -100.00 | -- | -- |
| Total Debt Issued | 80.40K | 346.00K | -- | -185.20K | -5.50K |
| Total Debt Repaid | -248.10K | -321.30K | -451.50K | -151.60K | -300.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -167.80K | 24.70K | -451.50K | -336.80K | -5.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00 | -1.40K | -28.60K | 20.30K | 9.50K |